Largest Share in the Market Is Claimed by the Commercial Segment

Noida, UP -- (SBWIRE) -- 04/23/2014 -- Increasing government support, better FDI inflows and increasing investment by private players are some of the major driving factors for growth of Russian Pharmaceutical Industry. The commercial drug segment occupied approximately 15% share in pharmaceutical market owing to the increasing consumer preferences for branded products and strengthening of Ruble. Besides, increasing healthcare spending and rising ageing population has been driving the sales in the commercial drug segment. Majority of drugs used in the country are imported which impacts the share of domestic pharmaceutical players in the commercial market. Therefore, the Russian Government has even introduced new policies and measures to restrict the access to imported medicines.